Emerging paradigm of consolidative thoracic radiotherapy in oligometastatic NSCLC Review
| Authors: | Gomez, D. R.; Yang, T. J.; Tsai, C. J. |
| Review Title: | Emerging paradigm of consolidative thoracic radiotherapy in oligometastatic NSCLC |
| Abstract: | The concept of oligometastatic disease has evolved substantially over the past decade. During this time, there has been a transition from retrospective and single-arm prospective studies to randomized evidence suggesting a benefit of local consolidative therapy (LCT) in the setting of limited metastatic non-small cell lung cancer. These trials had constraints and were thus limited in the strength of their conclusions, but led to several other ongoing randomized trials examining the role of LCT. These studies span various disease states (synchronous oligometastatic vs oligoprogressive), the scope of histologies included, and in how they define oligometastases. In addition, parallel biologic work is attempting to integrate relevant biomarkers and molecular classifications, with the ultimate goal of more precisely defining oligometastases and triaging patients to appropriate care. Finally, consensus guidelines have been initiated that provide a framework for designing future studies and for maintaining consistency across analyses that will facilitate the interpretation of results. This review describes the prior randomized data, the limitations therein, and future directions of clinical and preclinical studies that highlight the emerging paradigms for treatment of this select patient cohort. © 2020 |
| Journal Title: | Seminars in Radiation Oncology |
| Volume: | 31 |
| Issue: | 2 |
| ISSN: | 1053-4296 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2021-04-01 |
| Start Page: | 120 |
| End Page: | 123 |
| Language: | English |
| DOI: | 10.1016/j.semradonc.2020.11.008 |
| PUBMED: | 33610268 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Review -- Export Date: 1 April 2021 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work